IRON Financial LLC Invests $873,000 in The Clorox Company (NYSE:CLX)

IRON Financial LLC acquired a new stake in shares of The Clorox Company (NYSE:CLXFree Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,361 shares of the company’s stock, valued at approximately $873,000.

A number of other large investors also recently bought and sold shares of CLX. Innealta Capital LLC bought a new stake in shares of Clorox in the 2nd quarter valued at about $30,000. Trifecta Capital Advisors LLC increased its holdings in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares in the last quarter. First Foundation Advisors purchased a new stake in Clorox during the 1st quarter worth approximately $31,000. Family Firm Inc. acquired a new position in Clorox during the 2nd quarter valued at approximately $31,000. Finally, Quarry LP raised its holdings in shares of Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after buying an additional 114 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.51% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on CLX shares. Evercore ISI dropped their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Barclays upped their price objective on shares of Clorox from $130.00 to $137.00 and gave the company an “underweight” rating in a report on Friday, October 11th. TD Cowen started coverage on shares of Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective for the company. Finally, Wells Fargo & Company lowered their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research note on Wednesday, July 10th. Six equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox presently has an average rating of “Hold” and an average target price of $150.14.

Check Out Our Latest Research Report on CLX

Clorox Price Performance

Shares of NYSE CLX traded up $4.50 during midday trading on Thursday, hitting $161.01. The stock had a trading volume of 1,365,728 shares, compared to its average volume of 1,227,601. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.09. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The stock has a 50 day simple moving average of $161.14 and a 200-day simple moving average of $145.90. The company has a market capitalization of $20.00 billion, a PE ratio of 81.12, a P/E/G ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the firm posted $0.49 earnings per share. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. On average, sell-side analysts expect that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.03%. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.